Medicine and HealthCell Death and Disease
Photoactivatable oncolytic adenovirus for optogenetic cancer therapy
Y. Hagihara, A. Sakamoto, et al.
Discover the groundbreaking potential of the photoactivatable oncolytic adenovirus (paOAd), engineered by Yasuko Hagihara and team, to revolutionize cancer therapy. This innovative approach harnesses blue light to activate the virus, leading to remarkable tumor growth inhibition without harmful side effects when not triggered. A leap forward in targeting even the most resilient cancer stem cells.
Related Publications
Explore these studies to deepen your understanding
Adjacent work that informs or extends this paper's methodology and findings.
Engineering and Technology
Nanoparticles and convergence of artificial intelligence for targeted drug delivery for cancer therapy: Current progress and challenges
R. P. Singh, A. Natarajan, et al.
Medicine and Health
Enhanced plant-derived vesicles for nucleotide delivery for cancer therapy
S. Corvigno, Y. Liu, et al.
Medicine and Health
Recent advances in immunotherapy and molecular targeted therapy for gastric cancer
Y. Yoshinami and H. Shoji
Medicine and Health
Combining p53 mRNA nanotherapy with immune checkpoint blockade reprograms the immune microenvironment for effective cancer therapy
Y. Xiao, J. Chen, et al.
